Low doses of the anti-cancer drug imatinib can spur the bone marrow to produce more innate immune cells to fight against bacterial infections, Emory researchers have found.
from The Medical News http://ift.tt/19HUWt0
from The Medical News http://ift.tt/19HUWt0
No comments:
Post a Comment